Poly Medicure Ltd Company History

The Company has inaugurated its new manufacturing plant at Haridwar (Uttranchal).

The Company is setting up a project by way of wholly owned subsidiary in China to manufacture medical disposables with the investment of US $ 2 Million.

The Company has recommended a dividend @ 25% (Rs 2.50 Per equity shares of Rs 10/- each).

The Company is setting up the project for the manufacturing of "Medical Disposables" through it's subsidiary in China.

The Company has recommended a dividend @ 25% (Rs 2.50 per equity share of Rs 10 each).

The Company has recommended a dividend @ Rs 2.50 per equity share of Rs 10 each.

The Company has recommended Bonus Shares in proportion of One New Equity Share of Rs. 10/- each for every one existing Equity Shares of Rs. 10/- each in the ratio of 1:1.

The Company has recommended a dividend @ Rs. 2.50 per equity share of Rs. 10 each.

The Company has received a contract for supply of single Blood Bags for total consideration of INR 12.93 (Rupees Twelve Crore Ninety Three Lacs only) from Ministry of Health & Family Welfare, Department of AIDS Control, National AIDS Control Organization, Government of India through Rites Ltd., Bhawan, Plot No. 1, Sector-29, Gurgaon-122001 (Haryana), India.

The Company has appointed Ms. Sonia Singh, who is an associate member of the Institute of Company Secretaries of India, as Company Secretary of the Company and will also act as Compliance Officer of the Company.

The Company has recommended a dividend of Rs. 3 per equity share of Rs. 10 each.

The Company recommended a Dividend @ Rs. 3.00 per Equity Share of Rs. 10 each.

Poly Medicure have taken effective steps to set up Special Economic Zone unit at Jaipur for which it had acquired Industrial Plot area 16789.00 Square mtrs.

Poly Medicure has announces bonus in the ratio of 1:1

Poly Medicure recommended a Dividend @ Rs. 4 ( Four) per Equity Shares of Rs. 10 each.

The Registered office of the Company has been shifted from First Floor, 12, Sant Nagar, East of Kailash, New Delhi - 110 065 to Property No. 232B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi -110 020.

Poly Medicure, an Indian medical devices firm with annual sales of just over Rs 320 crore, has won a five-year long patent battle with Rs 40,000 crore German medical devices and pharma giant B Braun as the European Patent Office (EPO) revoked two of the latter's patents covering features of intravenous (IV) safety catheters.

Poly Medicure Ltd has received "GOLD" Patent Award for financial year 2014-15 on September 23, 2015 in recognition of commendable contribution in Medical Devices from Pharmaceuticals Export Promotion Council of India (Set up by Ministry of Commerce & Industry, Govt. of India).

The Company has also received ''First Position" Export Award for financial year 2014-15 on September 25, 2015 in the category of Plastic Medical Disposables from The Plastic Export Promotion Council (Sponsored by the Department of Commerce, Govt. of India).

During the Year, Company's Stock split from Rs. 10/- to Rs. 5/- each.

Company has issued Bonus Shares in the Ratio of 1:1.

Poly Medicure Limited has informed the Exchange regarding ''Intimation of Commencement of Commercial Production ''.

Company has been awarded as one of the Top 25 Innovative Companies by CII Industrial Innovation Awards 2019

Poly Medicure Ltd. productivity has increased due to sustained investments in automation.

Poly Medicure suggests how India needs to re-strategise a long-term roadmap for promoting the medical devices industry in the post-pandemic era.

Poly Medicure to enhance R&D capabilities to deliver high quality medical devices.

Poly Medicure Enabling quality primary healthcare through upskilling.

Poly Medicure will make India Atmanirbhar in medical device segment.

Poly Medicure Setting Up 2 Plants As Demand Rise.

Poly Medicure Wins India Medical Device Leader of the Year Award 2022 by Government of India.